These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30222709)

  • 1. Functional expression of human arylamine N-acetyltransferase NAT1*10 and NAT1*11 alleles: a mini review.
    Hein DW; Fakis G; Boukouvala S
    Pharmacogenet Genomics; 2018 Oct; 28(10):238-244. PubMed ID: 30222709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human acetyltransferase polymorphisms.
    Grant DM; Hughes NC; Janezic SA; Goodfellow GH; Chen HJ; Gaedigk A; Yu VL; Grewal R
    Mutat Res; 1997 May; 376(1-2):61-70. PubMed ID: 9202739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
    Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants.
    Payton MA; Sim E
    Biochem Pharmacol; 1998 Feb; 55(3):361-6. PubMed ID: 9484803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
    Smelt VA; Mardon HJ; Sim E
    Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.
    Wang D; Para MF; Koletar SL; Sadee W
    Pharmacogenet Genomics; 2011 Oct; 21(10):652-64. PubMed ID: 21878835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells.
    Wise JTF; Salazar-González RA; Habil MR; Doll MA; Hein DW
    Toxicol Appl Pharmacol; 2022 May; 442():115993. PubMed ID: 35353990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
    Hein DW
    Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster.
    Ferguson RJ; Doll MA; Rustan TD; Hein DW
    Pharmacogenetics; 1996 Feb; 6(1):55-66. PubMed ID: 8845861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli.
    Ferguson RJ; Doll MA; Rustan TD; Baumstark BR; Hein DW
    Pharmacogenetics; 1994 Apr; 4(2):82-90. PubMed ID: 8081415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1).
    Bruhn C; Brockmöller J; Cascorbi I; Roots I; Borchert HH
    Biochem Pharmacol; 1999 Dec; 58(11):1759-64. PubMed ID: 10571250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster.
    Hein DW; Doll MA; Xiao GH; Feng Y
    Pharmacogenetics; 2003 Mar; 13(3):159-67. PubMed ID: 12618593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: role of genetic and non genetic factors.
    Rodrigues-Lima F; Dupret JM
    Curr Pharm Des; 2004; 10(20):2519-24. PubMed ID: 15320760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel allele at the human NAT1 acetyltransferase locus.
    Doll MA; Jiang W; Deitz AC; Rustan TD; Hein DW
    Biochem Biophys Res Commun; 1997 Apr; 233(3):584-91. PubMed ID: 9168895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients.
    Risch A; Smelt V; Lane D; Stanley L; van der Slot W; Ward A; Sim E
    Pharmacol Toxicol; 1996 Apr; 78(4):235-40. PubMed ID: 8861781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population.
    Sekine A; Saito S; Iida A; Mitsunobu Y; Higuchi S; Harigae S; Nakamura Y
    J Hum Genet; 2001; 46(6):314-9. PubMed ID: 11393533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
    Liu L; Wagner CR; Hanna PE
    Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.